Molecular Characteristics of Methicillin-Resistant
Diabetic foot infection
Methicillin-resistant Staphylococcus aureus
SCCmec typing
Journal
Iranian journal of pathology
ISSN: 1735-5303
Titre abrégé: Iran J Pathol
Pays: Iran
ID NLM: 101515128
Informations de publication
Date de publication:
2019
2019
Historique:
received:
03
02
2019
accepted:
28
07
2019
entrez:
23
11
2019
pubmed:
23
11
2019
medline:
23
11
2019
Statut:
ppublish
Résumé
Diabetic foot ulcer (DFU), is one of the most frequent causes for hospitalizations in patients with diabetes. A major problem in the treatment of DFU is the increased-incidence of methicillin-resistant This study was carried out on 145 diabetic patients with DFUs. The antibiotic susceptibility tests (ASTs) were performed using the disk diffusion method and E-test technique. SCC In 145 samples from which The high prevalence of MRSA in DFUs represents the high levels of antibiotic usage among patients with diabetes. In this study, resistance to other important clinical antibiotics was detected among MRSA isolates. The high proportion of SCCmec type IV and V strains, even in former hospitalized patients, indicates the entrance of these clones to the clinical setting.
Sections du résumé
BACKGROUND & OBJECTIVE
OBJECTIVE
Diabetic foot ulcer (DFU), is one of the most frequent causes for hospitalizations in patients with diabetes. A major problem in the treatment of DFU is the increased-incidence of methicillin-resistant
METHODS
METHODS
This study was carried out on 145 diabetic patients with DFUs. The antibiotic susceptibility tests (ASTs) were performed using the disk diffusion method and E-test technique. SCC
RESULTS
RESULTS
In 145 samples from which
CONCLUSION
CONCLUSIONS
The high prevalence of MRSA in DFUs represents the high levels of antibiotic usage among patients with diabetes. In this study, resistance to other important clinical antibiotics was detected among MRSA isolates. The high proportion of SCCmec type IV and V strains, even in former hospitalized patients, indicates the entrance of these clones to the clinical setting.
Identifiants
pubmed: 31754364
doi: 10.30699/ijp.2019.101092.2035
pmc: PMC6824774
doi:
Types de publication
Journal Article
Langues
eng
Pagination
329-337Déclaration de conflit d'intérêts
The authors declared that there is no conflict of interest regarding the publication of this article.
Références
Diabetes Res Clin Pract. 2014 Feb;103(2):319-27
pubmed: 24447808
Diagn Microbiol Infect Dis. 2008 Jul;61(3):245-50
pubmed: 18272316
Diabetes Care. 2008 Dec;31(12):2318-24
pubmed: 18809632
Diabetes Res Clin Pract. 2012 Jan;95(1):153-61
pubmed: 22019426
Microb Pathog. 2017 Jun;107:409-412
pubmed: 28435108
J Biomed Sci. 2016 Mar 08;23:33
pubmed: 26952716
J Burns Wounds. 2007 Nov 16;7:e8
pubmed: 18091985
Am Fam Physician. 2002 Nov 1;66(9):1655-62
pubmed: 12449264
Ostomy Wound Manage. 2003 May;49(5A Suppl):8-13
pubmed: 12883159
J Diabetes Complications. 2008 Mar-Apr;22(2):77-82
pubmed: 18280436
Infect Immun. 2002 Feb;70(2):631-41
pubmed: 11796592
Diabet Med. 2003 Feb;20(2):159-61
pubmed: 12581269
J Hosp Infect. 2011 Nov;79(3):189-93
pubmed: 21741111
Int J Low Extrem Wounds. 2013 Jun;12(2):106-12
pubmed: 23771611
PLoS One. 2016 Aug 24;11(8):e0161658
pubmed: 27556897
Clin Infect Dis. 2003 Jan 15;36(2):131-9
pubmed: 12522744
Diabetes Metab. 2008 Sep;34(4 Pt 1):363-9
pubmed: 18632297
BMC Med. 2015 Jan 07;13:2
pubmed: 25564342
J Med Microbiol. 2016 Dec;65(12):1392-1404
pubmed: 27902390
Methods Mol Biol. 2014;1085:131-48
pubmed: 24085694
Eur J Clin Microbiol Infect Dis. 2012 Sep;31(9):2345-52
pubmed: 22354524
GMS Hyg Infect Control. 2015 Feb 02;10:Doc02
pubmed: 25699225
J Pathog. 2015;2015:328796
pubmed: 26843987
FEMS Microbiol Lett. 2015 Apr;362(8):fnv043
pubmed: 25795589
Iran J Public Health. 2010;39(1):8-14
pubmed: 23112984